CVS HEALTH (CVS) Stock: Buy, Sell, or Hold?
CVS - CVS HEALTH CORPORATION
$86.46
1.26 (1.48%)
▲
5d:
-3.0%
30d:
-11.08%
90d:
-15.3%
HOLD
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 04, 2026
Get Alerted When CVS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CVS shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: CVS shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$117.54
Based on 5.0% avg growth
INTRINSIC VALUE TODAY
$72.99
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 10.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CVS is currently trading at $86.46, which is considered oversold relative to its 30-day fair value range of $87.57 to $95.83. The stock's valuation (Forward PE: 10.1) is in line with its historical norms (10.8). Remarkably, the market is currently pricing in an annual earnings decline of 2.1% over the next few years. This pessimistic expectation contrasts with the company's recent 188.8% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, CVS is in a uptrend. The price is currently testing key support at $84.23. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CVS scores 87/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $116.28 (+34.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CVS is in a uptrend. The price is currently testing key support at $84.23. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CVS scores 87/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $116.28 (+34.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$87.57 -
$95.83
Company Quality Score
66/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
90.5%
Protect Your Profits
Holding CVS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (87/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 34.5% below Wall St target ($116.28)
- CAUTION: Bottoming setup, but lagging the sector by 25% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$87.57 -
$95.83
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$84.23
Resistance Level
$90.02
Current Trend
Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
10.14
Wall Street Target
$116.28
(+34.5%)
Revenue Growth (YoY)
7.1%
Earnings Growth (YoY)
188.8%
Profit Margin
1.2%
Valuation Discount vs History
-2.1% cheaper
PE vs Historical
10.1 vs 10.8
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.1%
(market-implied from PE analysis)
1-Year Target
$84.64
(-2%)
2-Year Target
$82.87
(-4%)
3-Year Target
$81.13
(-6%)
3-Yr Target (if PE normalizes)
(PE: 10→11)
$86.43
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.4, Growth: 6.0%)
$207.42
(+140%)
Base:
(SPY PE: 10.1, Growth: 6.0%)
$103.08
(+19%)
Bear:
(PE: 8.6, Growth: 6.0%)
$87.62
(+1%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (23x PE), but valuation improves significantly next year (10x PE) as earnings recover.
Trailing PE: 22.60 | Current EPS (TTM): $3.77
Bull Case
$187.44
(+117%)
Analyst growth 100.0%, PE expands to 24.9
Base Case
$170.40
(+97%)
Market implied 100.0%, PE stable at 22.6
Bear Case
$57.94
(-33%)
Severe decline -20.0%, PE contracts to 19.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 10.1 to 10.8
Stabilization Target:
$92.11
(+6.5%)
PE Expansion Potential:
+6.5%
Share & Embed Analysis
Last updated: October 02, 2026 9:46 PM ET
Data refreshes hourly during market hours. Next update: 10:46 PM
Data refreshes hourly during market hours. Next update: 10:46 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CVS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
UNH
UnitedHealth Group Incor… |
STRONG BUY
27 analysts |
$482 | 56 HOLD |
|
CI
Cigna Corp |
STRONG BUY
25 analysts |
$342 | 51 HOLD |
|
ELV
Elevance Health Inc |
STRONG BUY
22 analysts |
$451 | 45 HOLD |
|
HUM
Humana Inc |
HOLD
26 analysts |
$424 | 65 BUY |
|
CNC
Centene Corp |
BUY
19 analysts |
$72 | 54 HOLD |
Advanced CVS Option Strategies
Professional options setups generated by AI based on today's CVS price and gamma walls.
